SUCO
Basic information
Region (hg38): 1:172532349-172611833
Previous symbols: [ "C1orf9" ]
Links
Phenotypes
GenCC
Source:
- temporal lobe epilepsy (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SUCO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 68 | 74 | ||||
missense | 174 | 186 | ||||
nonsense | 2 | |||||
start loss | 2 | |||||
frameshift | 4 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 5 | 11 | 2 | 18 | ||
non coding | 20 | 47 | 73 | |||
Total | 0 | 0 | 204 | 122 | 19 |
Variants in SUCO
This is a list of pathogenic ClinVar variants found in the SUCO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-172532477-G-C | SUCO-related disorder | Benign (Jan 27, 2020) | ||
1-172532503-T-C | SUCO-related disorder | Benign (Oct 31, 2019) | ||
1-172533172-A-T | SUCO-related disorder | Benign (Nov 14, 2019) | ||
1-172533200-T-C | SUCO-related disorder | Benign (Oct 31, 2019) | ||
1-172533466-G-A | Uncertain significance (Nov 15, 2023) | |||
1-172533467-T-G | not specified | Uncertain significance (Dec 16, 2023) | ||
1-172533477-C-T | SUCO-related disorder | Benign (Jan 29, 2024) | ||
1-172533496-T-C | Uncertain significance (Mar 13, 2022) | |||
1-172533507-C-G | Likely benign (Nov 23, 2022) | |||
1-172533508-GCGA-G | Likely benign (Mar 19, 2023) | |||
1-172533510-G-A | Likely benign (Nov 08, 2022) | |||
1-172533512-C-A | Likely benign (Aug 23, 2022) | |||
1-172533515-C-A | Likely benign (Dec 20, 2022) | |||
1-172551508-A-G | Likely benign (Jan 04, 2024) | |||
1-172551525-C-T | not specified | Uncertain significance (Sep 03, 2023) | ||
1-172551526-G-A | Uncertain significance (Aug 10, 2022) | |||
1-172551530-A-G | Likely benign (Nov 10, 2023) | |||
1-172551538-AAG-A | Uncertain significance (Sep 26, 2021) | |||
1-172551540-G-A | Uncertain significance (Feb 04, 2023) | |||
1-172551552-G-A | SUCO-related disorder | Benign (Jan 02, 2024) | ||
1-172551559-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
1-172551560-G-A | Likely benign (Dec 18, 2023) | |||
1-172551570-T-C | not specified | Uncertain significance (Feb 21, 2024) | ||
1-172551578-A-T | Uncertain significance (Sep 23, 2023) | |||
1-172551580-A-G | not specified | Conflicting classifications of pathogenicity (Mar 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SUCO | protein_coding | protein_coding | ENST00000263688 | 24 | 79483 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.975 | 0.0255 | 125573 | 1 | 169 | 125743 | 0.000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.08 | 555 | 631 | 0.879 | 0.0000311 | 8170 |
Missense in Polyphen | 118 | 180.76 | 0.65279 | 2379 | ||
Synonymous | 0.00276 | 222 | 222 | 1.00 | 0.0000112 | 2377 |
Loss of Function | 6.04 | 12 | 64.2 | 0.187 | 0.00000329 | 860 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000196 | 0.000189 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000114 | 0.000109 |
Finnish | 0.000141 | 0.000139 |
European (Non-Finnish) | 0.000242 | 0.000237 |
Middle Eastern | 0.000114 | 0.000109 |
South Asian | 0.00461 | 0.00429 |
Other | 0.000675 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Required for bone modeling during late embryogenesis. Regulates type I collagen synthesis in osteoblasts during their postnatal maturation (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.235
Intolerance Scores
- loftool
- rvis_EVS
- -1.24
- rvis_percentile_EVS
- 5.52
Haploinsufficiency Scores
- pHI
- 0.0578
- hipred
- N
- hipred_score
- 0.384
- ghis
- 0.563
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Suco
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype;
Gene ontology
- Biological process
- ossification;multicellular organism development;positive regulation of collagen biosynthetic process;protein folding in endoplasmic reticulum;positive regulation of osteoblast differentiation;regulation of bone remodeling
- Cellular component
- cytoplasm;rough endoplasmic reticulum;membrane;integral component of membrane;rough endoplasmic reticulum membrane
- Molecular function